Ушбу ишга иқтибос қилган ишлар

2 та иш

Иш: The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells

1. COVID-19: well-known drugs, new opportunities

   Uzbekistan’s Public Healthcare Ministry, 26 Spitamena Str., Tashkent, 100121, Uzbekistan, А Х Аширметов, I.R. Mavlyanov +2

   МақолаVitamin C and Antioxidants ResearchHealth risk analysis20200 иқтибос

   ABIABI:AkademIndex/openalex/2020.article.000769

2. ACHIEVEMENTS AND PROSPECTS OF SCIENTIFIC RESEARCH: COVID-19 INFECTION

   Iskandar Mavlyanov, Z.I. Mavlyanov, А Х Аширметов

   МақолаCOVID-19 Clinical Research StudiesJournal of science and innovative development20200 иқтибос

   ABIABI:AkademIndex/openalex/2020.article.005380